🇺🇸 FDA
Patent

US 10428132

Tumor necrosis factor-related apoptosis-inducing ligand variant, as well as a preparation method and use thereof

granted A61KA61K38/00

Quick answer

US patent 10428132 (Tumor necrosis factor-related apoptosis-inducing ligand variant, as well as a preparation method and use thereof) held by WEST CHINA HOSPITAL, SICHUAN UNIVERSITY expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
WEST CHINA HOSPITAL, SICHUAN UNIVERSITY
Grant date
Tue Oct 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K38/00